⌘K

Login Start Free

Home/Filings/4/0001235802-20-000054

4//SEC Filing

Kellen Scott 4

Accession 0001235802-20-000054

CIK 0001401040other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:28 PM ET

Size

5.9 KB

Accession

0001235802-20-000054

Insider Transaction Report

Form 4

Period: 2020-06-01

DiaMedica Therapeutics Inc.DMAC

CFO & Secretary

Transactions

Award
Stock Option (right to buy)
2020-06-01+35,000→ 35,000 total
Exercise: $4.64Exp: 2030-05-31→ Common Shares (35,000 underlying)

Holdings

Voting Common Shares, no par value per share
10,290

Footnotes (1)

[F1]Vests in twelve nearly equal quarterly installments commencing on September 1, 2020.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1

filerCIK 0001490476

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 5:28 PM ET
Size: 5.9 KB

View on SEC.gov